Oxford Biomedica (OXB) News Today → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free OXB Stock Alerts GBX 228.50 +8.50 (+3.86%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOxford BioMedica plc: Update to Medium-Term Financial Guidance and 2023 Trading and Notice of Preliminary Resultsfinanznachrichten.de - March 5 at 2:30 PMUpdate to Medium-Term Financial Guidance and 2023 Trading and Notice of Preliminary Resultsfinance.yahoo.com - March 5 at 9:30 AMOxford Biomedica (LON:OXB) Share Price Crosses Below Two Hundred Day Moving Average of $251.96marketbeat.com - February 10 at 4:13 AMEnSilica hires new chief financial officer from Oxford Biomedicalse.co.uk - February 5 at 7:33 AMOxford Biomedica (LON:OXB) Shares Pass Below Two Hundred Day Moving Average of $263.21marketbeat.com - February 2 at 4:23 AMOxford Biomedica completes acquisition of ABL Europefinance.yahoo.com - January 29 at 8:31 AMOxford Biomedica (LON:OXB) shareholders have endured a 79% loss from investing in the stock three years agofinance.yahoo.com - December 19 at 1:19 AMOxford Biomedica inks deal to provide ‘footprint’ in EU marketmsn.com - December 4 at 7:21 AMOxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position as a global pure-play CDMOfinance.yahoo.com - December 4 at 7:21 AMOxford Biomedica's UK£39m Market Cap Fall Books Insider Lossesfinance.yahoo.com - October 22 at 8:52 AMOxford Biomedica First Half 2023 Earnings: Misses Expectationsfinance.yahoo.com - September 22 at 9:55 AMOxford BioMedica shares soar as vaccine maker raises earnings guidancefinance.yahoo.com - September 20 at 9:45 AMOxford Biomedica Implements Sapio Sciences' Electronic Laboratory Notebookfinance.yahoo.com - July 18 at 10:33 AMRBC Capital Markets Reiterates Oxford Biomedica (LSE:OXB) Outperform Recommendationmsn.com - May 25 at 10:44 PMOxford Biomedica launches TetraVecta - the next generation lentiviral vector systemfinance.yahoo.com - May 15 at 7:51 AMWhy Investors Shouldn't Be Surprised By Oxford Biomedica plc's (LON:OXB) Low P/Sfinance.yahoo.com - May 5 at 1:18 PMOxford Biomedica Appoints Leone Patterson as Non-Executive Directorfinance.yahoo.com - April 26 at 7:26 AMOxford Biomedica Posts FY Lossmarkets.businessinsider.com - April 25 at 9:31 AM2023-2030 "CGT CDMO Market" Share | Global Industry Analysis and Forecastmarketwatch.com - April 21 at 9:14 AM2023-2030 Global CGT CDMO Market is Growing Rapidly with Modern Trendmarketwatch.com - April 12 at 6:42 PMCGT CDMO Market Share and Forecast till 2030marketwatch.com - March 26 at 1:57 PMOxford BioMedica Stock (OTC:OXBDF), Quotes and News Summarybenzinga.com - March 15 at 10:05 AMAs Oxford Biomedica plc's market cap (LON:OXB) drops to UK£484m, insiders might be questioning their decision to buy earlier this yearfinance.yahoo.com - March 11 at 4:10 AMWhat is a CAGR of CGT CDMO Market? CGT CDMO Market Value in 2028 with Competition Analysis Data of Top Key Playersmarketwatch.com - February 25 at 10:28 AMCGT CDMO Market Size Global Research Report, 2023 - 2028marketwatch.com - February 22 at 6:43 PMCGT CDMO Market Size 2023 Trend and Opportunities, Analysis, CAGR and Value Chain Study, Business Growth to 2028marketwatch.com - January 30 at 9:25 AMCGT CDMO Market Provides an In-Depth Insight of Trends and Landscape Outlook 2023-2028marketwatch.com - January 20 at 10:21 AMCGT CDMO Market Present Development Scenario and Growth Prospects to help you understand the Implications for Your Business | Newest 112 Insightsmarketwatch.com - January 12 at 3:55 AMA Look At The Intrinsic Value Of Oxford Biomedica plc (LON:OXB)finance.yahoo.com - January 1 at 5:30 AMOxford Biomedica Solutions forms new partnerships with three biotechnology companiesyahoo.com - December 14 at 1:57 PMCGT CDMO Market 2022 : Incredible Possibilities, Growth Analysis and Forecast To 2028marketwatch.com - December 9 at 2:48 AMOxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officerfinance.yahoo.com - November 22 at 12:18 PMCGT CDMO Market Size 2022 Is Changing Consumer Habits, this Industry in the Globe Has Noticed Substantial Growth to 2028 | 112 Pages Reportmarketwatch.com - October 25 at 3:17 AMAmendment of Short-Term Loan Facility into new Term Loan Facility With Oaktreefinance.yahoo.com - October 7 at 8:03 AMBullish Oxford Biomedica plc (LON:OXB) insiders filled their treasuries with UK£658k worth of stock over last yearfinance.yahoo.com - September 29 at 3:16 AMEdited Transcript of OXB.L earnings conference call or presentation 15-Sep-22 12:00pm GMTfinance.yahoo.com - September 15 at 8:51 PMFTSE: Oxford Biomedica sees revenue drop as COVID vaccine demand dropsuk.finance.yahoo.com - September 15 at 5:49 AMOxford Biomedica Solutions signs agreement with new partner to deliver The Full Solution for their AAV programsfinance.yahoo.com - September 14 at 8:36 AMOxford Biomedica plc (OXB.L)finance.yahoo.com - September 12 at 11:34 PMOxford Biomedica signs new deal to make AstraZeneca COVID shotmsn.com - July 1 at 10:19 PMOxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccinefinance.yahoo.com - July 1 at 9:56 AMOxford Biomedica extends deal with AstraZeneca to make Covid vaccines on an as-needed basismsn.com - July 1 at 4:47 AMOxford Biomedica, AstraZeneca Extend COVID-19 Vaccine Manufacturing Partnershipnasdaq.com - July 1 at 4:47 AMOxford Biomedica: FDA Lifts Clinical Hold On Homology Medicines' PheNIX Trialnasdaq.com - June 14 at 4:37 AMOxford Biomedica broadens its viral vector capabilities with the launch of Oxford Biomedica Solutions, a full scope AAV business in Boston, following closing of its deal with Homologyfinance.yahoo.com - March 11 at 8:20 AMOxford Biomedica broadens leading viral vector offerings bytmcnet.com - January 28 at 7:59 AMBritain's Oxford Biomedica enters into deal to expand viral vector offeringsmsn.com - January 28 at 7:59 AMOxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into a newly formed AAV Manufacturing and Innovation Business in the US with Homology Medicines as 20% ownerfinance.yahoo.com - January 28 at 2:58 AM1 FTSE 250 to buy for long-term growthuk.finance.yahoo.com - January 25 at 3:24 PMVirica Biotech Announces R&D Partnership With...benzinga.com - January 24 at 9:59 AM Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. OXB Media Mentions By Week OXB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OXB News Sentiment▼0.000.32▲Average Medical News Sentiment OXB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OXB Articles This Week▼00▲OXB Articles Average Week Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: hVIVO News Arix Bioscience News Avacta Group News Bioventix News Futura Medical News Scancell News Faron Pharmaceuticals Oy News e-therapeutics News Poolbeg Pharma News PureTech Health News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OXB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
